nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—SLC6A4—chronic obstructive pulmonary disease	0.189	0.523	CbGaD
Verapamil—CYP1A2—chronic obstructive pulmonary disease	0.172	0.477	CbGaD
Verapamil—SLC22A4—Tiotropium—chronic obstructive pulmonary disease	0.0932	0.228	CbGbCtD
Verapamil—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.0527	0.129	CbGbCtD
Verapamil—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.0247	0.0604	CbGbCtD
Verapamil—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.0233	0.057	CbGbCtD
Verapamil—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0186	0.0455	CbGbCtD
Verapamil—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0186	0.0455	CbGbCtD
Verapamil—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0168	0.0411	CbGbCtD
Verapamil—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0155	0.0378	CbGbCtD
Verapamil—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0155	0.0378	CbGbCtD
Verapamil—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0146	0.0357	CbGbCtD
Verapamil—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0141	0.0346	CbGbCtD
Verapamil—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0141	0.0346	CbGbCtD
Verapamil—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0126	0.0308	CbGbCtD
Verapamil—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0119	0.029	CbGbCtD
Verapamil—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0117	0.0286	CbGbCtD
Verapamil—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00801	0.0196	CbGbCtD
Verapamil—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00781	0.0191	CbGbCtD
Verapamil—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00764	0.0187	CbGbCtD
Verapamil—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00681	0.0167	CbGbCtD
Verapamil—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00667	0.0163	CbGbCtD
Verapamil—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0063	0.0154	CbGbCtD
Verapamil—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.004	0.00977	CbGbCtD
Verapamil—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00377	0.00923	CbGbCtD
Verapamil—Tofisopam—PDE4A—chronic obstructive pulmonary disease	0.00306	0.767	CrCbGaD
Verapamil—CACNA1B—respiratory system—chronic obstructive pulmonary disease	0.00157	0.0692	CbGeAlD
Verapamil—CACNA1B—connective tissue—chronic obstructive pulmonary disease	0.00138	0.0609	CbGeAlD
Verapamil—CACNB3—bronchus—chronic obstructive pulmonary disease	0.00106	0.0468	CbGeAlD
Verapamil—CACNB3—trachea—chronic obstructive pulmonary disease	0.000954	0.0421	CbGeAlD
Verapamil—Bevantolol—ADRB2—chronic obstructive pulmonary disease	0.000931	0.233	CrCbGaD
Verapamil—CACNB4—lung—chronic obstructive pulmonary disease	0.000895	0.0395	CbGeAlD
Verapamil—CYP2C18—bronchus—chronic obstructive pulmonary disease	0.000846	0.0373	CbGeAlD
Verapamil—CACNA1B—lung—chronic obstructive pulmonary disease	0.000834	0.0368	CbGeAlD
Verapamil—CACNA1H—smooth muscle tissue—chronic obstructive pulmonary disease	0.000739	0.0326	CbGeAlD
Verapamil—CACNA1C—respiratory system—chronic obstructive pulmonary disease	0.0007	0.0309	CbGeAlD
Verapamil—CACNB3—lung—chronic obstructive pulmonary disease	0.000685	0.0302	CbGeAlD
Verapamil—ABCC3—respiratory system—chronic obstructive pulmonary disease	0.000636	0.0281	CbGeAlD
Verapamil—CACNA1C—connective tissue—chronic obstructive pulmonary disease	0.000616	0.0272	CbGeAlD
Verapamil—SLC22A4—respiratory system—chronic obstructive pulmonary disease	0.000595	0.0263	CbGeAlD
Verapamil—CACNA1C—smooth muscle tissue—chronic obstructive pulmonary disease	0.000563	0.0248	CbGeAlD
Verapamil—SLC6A4—respiratory system—chronic obstructive pulmonary disease	0.000527	0.0233	CbGeAlD
Verapamil—ABCC10—bronchus—chronic obstructive pulmonary disease	0.000521	0.023	CbGeAlD
Verapamil—SLC22A4—bronchus—chronic obstructive pulmonary disease	0.00049	0.0216	CbGeAlD
Verapamil—ABCC10—trachea—chronic obstructive pulmonary disease	0.000468	0.0206	CbGeAlD
Verapamil—CACNB2—lung—chronic obstructive pulmonary disease	0.00046	0.0203	CbGeAlD
Verapamil—SLC22A4—trachea—chronic obstructive pulmonary disease	0.00044	0.0194	CbGeAlD
Verapamil—ABCC4—bronchus—chronic obstructive pulmonary disease	0.000432	0.0191	CbGeAlD
Verapamil—CACNA1D—lung—chronic obstructive pulmonary disease	0.000402	0.0177	CbGeAlD
Verapamil—SLC22A5—respiratory system—chronic obstructive pulmonary disease	0.000394	0.0174	CbGeAlD
Verapamil—CACNA1C—lung—chronic obstructive pulmonary disease	0.000371	0.0164	CbGeAlD
Verapamil—ABCC1—bronchus—chronic obstructive pulmonary disease	0.000369	0.0163	CbGeAlD
Verapamil—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000357	0.0157	CbGeAlD
Verapamil—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000344	0.0152	CbGeAlD
Verapamil—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000342	0.0151	CbGeAlD
Verapamil—ABCC3—lung—chronic obstructive pulmonary disease	0.000338	0.0149	CbGeAlD
Verapamil—ABCC10—lung—chronic obstructive pulmonary disease	0.000336	0.0148	CbGeAlD
Verapamil—ABCC1—trachea—chronic obstructive pulmonary disease	0.000331	0.0146	CbGeAlD
Verapamil—SLC22A5—bronchus—chronic obstructive pulmonary disease	0.000324	0.0143	CbGeAlD
Verapamil—SLC22A4—lung—chronic obstructive pulmonary disease	0.000316	0.0139	CbGeAlD
Verapamil—SLC22A5—trachea—chronic obstructive pulmonary disease	0.000291	0.0128	CbGeAlD
Verapamil—SLCO1A2—lung—chronic obstructive pulmonary disease	0.00029	0.0128	CbGeAlD
Verapamil—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.000282	0.0124	CbGeAlD
Verapamil—SLC6A4—lung—chronic obstructive pulmonary disease	0.00028	0.0123	CbGeAlD
Verapamil—ABCC4—lung—chronic obstructive pulmonary disease	0.000279	0.0123	CbGeAlD
Verapamil—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000263	0.00216	CcSEcCtD
Verapamil—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.00215	CcSEcCtD
Verapamil—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000262	0.00215	CcSEcCtD
Verapamil—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.000257	0.00212	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000257	0.00211	CcSEcCtD
Verapamil—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.00211	CcSEcCtD
Verapamil—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000257	0.00211	CcSEcCtD
Verapamil—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000256	0.00211	CcSEcCtD
Verapamil—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000255	0.0021	CcSEcCtD
Verapamil—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000255	0.0021	CcSEcCtD
Verapamil—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000255	0.0021	CcSEcCtD
Verapamil—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000253	0.00208	CcSEcCtD
Verapamil—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000253	0.00208	CcSEcCtD
Verapamil—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000251	0.00207	CcSEcCtD
Verapamil—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00025	0.00205	CcSEcCtD
Verapamil—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000248	0.00204	CcSEcCtD
Verapamil—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.00203	CcSEcCtD
Verapamil—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000247	0.00203	CcSEcCtD
Verapamil—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.00203	CcSEcCtD
Verapamil—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00199	CcSEcCtD
Verapamil—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00199	CcSEcCtD
Verapamil—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000241	0.00198	CcSEcCtD
Verapamil—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000241	0.00198	CcSEcCtD
Verapamil—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.00198	CcSEcCtD
Verapamil—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.00198	CcSEcCtD
Verapamil—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000239	0.00196	CcSEcCtD
Verapamil—ABCC1—lung—chronic obstructive pulmonary disease	0.000238	0.0105	CbGeAlD
Verapamil—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000238	0.00195	CcSEcCtD
Verapamil—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00195	CcSEcCtD
Verapamil—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00195	CcSEcCtD
Verapamil—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00195	CcSEcCtD
Verapamil—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00195	CcSEcCtD
Verapamil—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00195	CcSEcCtD
Verapamil—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00195	CcSEcCtD
Verapamil—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000237	0.00195	CcSEcCtD
Verapamil—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00195	CcSEcCtD
Verapamil—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00194	CcSEcCtD
Verapamil—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000235	0.00193	CcSEcCtD
Verapamil—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.00193	CcSEcCtD
Verapamil—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.00191	CcSEcCtD
Verapamil—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000233	0.00191	CcSEcCtD
Verapamil—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000233	0.00191	CcSEcCtD
Verapamil—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000232	0.00191	CcSEcCtD
Verapamil—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000232	0.00191	CcSEcCtD
Verapamil—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.0019	CcSEcCtD
Verapamil—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.00187	CcSEcCtD
Verapamil—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.00187	CcSEcCtD
Verapamil—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000228	0.00187	CcSEcCtD
Verapamil—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000228	0.00187	CcSEcCtD
Verapamil—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.00187	CcSEcCtD
Verapamil—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000227	0.00187	CcSEcCtD
Verapamil—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00186	CcSEcCtD
Verapamil—Infection—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00186	CcSEcCtD
Verapamil—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.00184	CcSEcCtD
Verapamil—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.00184	CcSEcCtD
Verapamil—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.00184	CcSEcCtD
Verapamil—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000224	0.00184	CcSEcCtD
Verapamil—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000224	0.00184	CcSEcCtD
Verapamil—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000223	0.00183	CcSEcCtD
Verapamil—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000223	0.00183	CcSEcCtD
Verapamil—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000222	0.00183	CcSEcCtD
Verapamil—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.00183	CcSEcCtD
Verapamil—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00182	CcSEcCtD
Verapamil—Infection—Montelukast—chronic obstructive pulmonary disease	0.000222	0.00182	CcSEcCtD
Verapamil—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000221	0.00182	CcSEcCtD
Verapamil—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000221	0.00181	CcSEcCtD
Verapamil—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.0018	CcSEcCtD
Verapamil—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000219	0.0018	CcSEcCtD
Verapamil—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.00177	CcSEcCtD
Verapamil—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.00177	CcSEcCtD
Verapamil—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00176	CcSEcCtD
Verapamil—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000213	0.00175	CcSEcCtD
Verapamil—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000213	0.00175	CcSEcCtD
Verapamil—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000212	0.00174	CcSEcCtD
Verapamil—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00174	CcSEcCtD
Verapamil—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.00174	CcSEcCtD
Verapamil—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00173	CcSEcCtD
Verapamil—SLC22A5—lung—chronic obstructive pulmonary disease	0.000209	0.00923	CbGeAlD
Verapamil—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000208	0.00171	CcSEcCtD
Verapamil—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.00171	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000208	0.00171	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.00171	CcSEcCtD
Verapamil—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000206	0.00169	CcSEcCtD
Verapamil—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.00169	CcSEcCtD
Verapamil—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000205	0.00168	CcSEcCtD
Verapamil—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00168	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000203	0.00167	CcSEcCtD
Verapamil—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.00167	CcSEcCtD
Verapamil—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000203	0.00167	CcSEcCtD
Verapamil—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000203	0.00166	CcSEcCtD
Verapamil—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.00166	CcSEcCtD
Verapamil—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000202	0.00166	CcSEcCtD
Verapamil—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.00165	CcSEcCtD
Verapamil—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00165	CcSEcCtD
Verapamil—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00165	CcSEcCtD
Verapamil—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.0002	0.00165	CcSEcCtD
Verapamil—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.0002	0.00164	CcSEcCtD
Verapamil—Injury—Prednisone—chronic obstructive pulmonary disease	0.000198	0.00163	CcSEcCtD
Verapamil—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000198	0.00163	CcSEcCtD
Verapamil—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000198	0.00163	CcSEcCtD
Verapamil—ABCG2—lung—chronic obstructive pulmonary disease	0.000197	0.00868	CbGeAlD
Verapamil—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00161	CcSEcCtD
Verapamil—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00161	CcSEcCtD
Verapamil—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00161	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.00161	CcSEcCtD
Verapamil—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.0016	CcSEcCtD
Verapamil—Pain—Formoterol—chronic obstructive pulmonary disease	0.000195	0.0016	CcSEcCtD
Verapamil—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000195	0.0016	CcSEcCtD
Verapamil—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.0016	CcSEcCtD
Verapamil—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.0016	CcSEcCtD
Verapamil—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00159	CcSEcCtD
Verapamil—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00158	CcSEcCtD
Verapamil—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00158	CcSEcCtD
Verapamil—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00157	CcSEcCtD
Verapamil—Pain—Montelukast—chronic obstructive pulmonary disease	0.000191	0.00157	CcSEcCtD
Verapamil—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.00157	CcSEcCtD
Verapamil—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00019	0.00156	CcSEcCtD
Verapamil—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.00156	CcSEcCtD
Verapamil—CYP1A2—lung—chronic obstructive pulmonary disease	0.000189	0.00836	CbGeAlD
Verapamil—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00156	CcSEcCtD
Verapamil—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00156	CcSEcCtD
Verapamil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000189	0.00155	CcSEcCtD
Verapamil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000189	0.00155	CcSEcCtD
Verapamil—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.00154	CcSEcCtD
Verapamil—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000188	0.00154	CcSEcCtD
Verapamil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000188	0.00154	CcSEcCtD
Verapamil—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00154	CcSEcCtD
Verapamil—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000187	0.00153	CcSEcCtD
Verapamil—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000186	0.00153	CcSEcCtD
Verapamil—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00152	CcSEcCtD
Verapamil—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00151	CcSEcCtD
Verapamil—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00151	CcSEcCtD
Verapamil—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000183	0.00806	CbGeAlD
Verapamil—CYP3A5—lung—chronic obstructive pulmonary disease	0.000183	0.00806	CbGeAlD
Verapamil—CYP2B6—lung—chronic obstructive pulmonary disease	0.000182	0.00801	CbGeAlD
Verapamil—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.00149	CcSEcCtD
Verapamil—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000181	0.00149	CcSEcCtD
Verapamil—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000179	0.00148	CcSEcCtD
Verapamil—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000178	0.00146	CcSEcCtD
Verapamil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000178	0.00146	CcSEcCtD
Verapamil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000178	0.00146	CcSEcCtD
Verapamil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000178	0.00146	CcSEcCtD
Verapamil—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000177	0.00146	CcSEcCtD
Verapamil—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00146	CcSEcCtD
Verapamil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000177	0.00145	CcSEcCtD
Verapamil—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.00145	CcSEcCtD
Verapamil—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000173	0.00143	CcSEcCtD
Verapamil—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.0014	CcSEcCtD
Verapamil—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00138	CcSEcCtD
Verapamil—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00138	CcSEcCtD
Verapamil—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000168	0.00138	CcSEcCtD
Verapamil—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.00138	CcSEcCtD
Verapamil—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000164	0.00135	CcSEcCtD
Verapamil—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.00134	CcSEcCtD
Verapamil—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000163	0.00134	CcSEcCtD
Verapamil—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00132	CcSEcCtD
Verapamil—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00132	CcSEcCtD
Verapamil—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00132	CcSEcCtD
Verapamil—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00132	CcSEcCtD
Verapamil—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.0013	CcSEcCtD
Verapamil—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000158	0.0013	CcSEcCtD
Verapamil—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.00128	CcSEcCtD
Verapamil—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000156	0.00128	CcSEcCtD
Verapamil—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00127	CcSEcCtD
Verapamil—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00126	CcSEcCtD
Verapamil—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000153	0.00126	CcSEcCtD
Verapamil—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00125	CcSEcCtD
Verapamil—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.00124	CcSEcCtD
Verapamil—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000151	0.00124	CcSEcCtD
Verapamil—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000148	0.00121	CcSEcCtD
Verapamil—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00121	CcSEcCtD
Verapamil—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00119	CcSEcCtD
Verapamil—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000145	0.00119	CcSEcCtD
Verapamil—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.00119	CcSEcCtD
Verapamil—Rash—Formoterol—chronic obstructive pulmonary disease	0.000144	0.00118	CcSEcCtD
Verapamil—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.00118	CcSEcCtD
Verapamil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000144	0.00118	CcSEcCtD
Verapamil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.00118	CcSEcCtD
Verapamil—Headache—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00117	CcSEcCtD
Verapamil—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00117	CcSEcCtD
Verapamil—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.00117	CcSEcCtD
Verapamil—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.00117	CcSEcCtD
Verapamil—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000142	0.00117	CcSEcCtD
Verapamil—Rash—Montelukast—chronic obstructive pulmonary disease	0.000141	0.00116	CcSEcCtD
Verapamil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000141	0.00116	CcSEcCtD
Verapamil—Headache—Montelukast—chronic obstructive pulmonary disease	0.00014	0.00115	CcSEcCtD
Verapamil—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00114	CcSEcCtD
Verapamil—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.00114	CcSEcCtD
Verapamil—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00113	CcSEcCtD
Verapamil—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.00112	CcSEcCtD
Verapamil—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00112	CcSEcCtD
Verapamil—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.00111	CcSEcCtD
Verapamil—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00111	CcSEcCtD
Verapamil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.00111	CcSEcCtD
Verapamil—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.00111	CcSEcCtD
Verapamil—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000135	0.00111	CcSEcCtD
Verapamil—ABCB1—trachea—chronic obstructive pulmonary disease	0.000135	0.00596	CbGeAlD
Verapamil—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00111	CcSEcCtD
Verapamil—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.00109	CcSEcCtD
Verapamil—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000133	0.00109	CcSEcCtD
Verapamil—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.00108	CcSEcCtD
Verapamil—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.00107	CcSEcCtD
Verapamil—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00106	CcSEcCtD
Verapamil—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00105	CcSEcCtD
Verapamil—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.00105	CcSEcCtD
Verapamil—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00101	CcSEcCtD
Verapamil—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00101	CcSEcCtD
Verapamil—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.000998	CcSEcCtD
Verapamil—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.00099	CcSEcCtD
Verapamil—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.00098	CcSEcCtD
Verapamil—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000963	CcSEcCtD
Verapamil—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000917	CcSEcCtD
Verapamil—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000917	CcSEcCtD
Verapamil—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000911	CcSEcCtD
Verapamil—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000867	CcSEcCtD
Verapamil—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000851	CcSEcCtD
Verapamil—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000836	CcSEcCtD
Verapamil—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00083	CcSEcCtD
Verapamil—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000825	CcSEcCtD
Verapamil—Vertigo—Prednisone—chronic obstructive pulmonary disease	9.87e-05	0.000811	CcSEcCtD
Verapamil—Syncope—Prednisone—chronic obstructive pulmonary disease	9.85e-05	0.00081	CcSEcCtD
Verapamil—Urticaria—Prednisolone—chronic obstructive pulmonary disease	9.8e-05	0.000806	CcSEcCtD
Verapamil—ABCB1—lung—chronic obstructive pulmonary disease	9.71e-05	0.00428	CbGeAlD
Verapamil—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	9.66e-05	0.000794	CcSEcCtD
Verapamil—Convulsion—Prednisone—chronic obstructive pulmonary disease	9.52e-05	0.000782	CcSEcCtD
Verapamil—Hypertension—Prednisone—chronic obstructive pulmonary disease	9.48e-05	0.00078	CcSEcCtD
Verapamil—Myalgia—Prednisone—chronic obstructive pulmonary disease	9.35e-05	0.000769	CcSEcCtD
Verapamil—Arthralgia—Prednisone—chronic obstructive pulmonary disease	9.35e-05	0.000769	CcSEcCtD
Verapamil—Discomfort—Prednisone—chronic obstructive pulmonary disease	9.24e-05	0.00076	CcSEcCtD
Verapamil—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	9.09e-05	0.000747	CcSEcCtD
Verapamil—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	8.97e-05	0.000737	CcSEcCtD
Verapamil—Oedema—Prednisone—chronic obstructive pulmonary disease	8.97e-05	0.000737	CcSEcCtD
Verapamil—Infection—Prednisone—chronic obstructive pulmonary disease	8.91e-05	0.000732	CcSEcCtD
Verapamil—Shock—Prednisone—chronic obstructive pulmonary disease	8.82e-05	0.000725	CcSEcCtD
Verapamil—Tachycardia—Prednisone—chronic obstructive pulmonary disease	8.75e-05	0.000719	CcSEcCtD
Verapamil—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	8.67e-05	0.000712	CcSEcCtD
Verapamil—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	8.17e-05	0.000671	CcSEcCtD
Verapamil—Dizziness—Prednisolone—chronic obstructive pulmonary disease	8.16e-05	0.000671	CcSEcCtD
Verapamil—Insomnia—Prednisone—chronic obstructive pulmonary disease	8.11e-05	0.000667	CcSEcCtD
Verapamil—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	8.05e-05	0.000662	CcSEcCtD
Verapamil—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	7.89e-05	0.000649	CcSEcCtD
Verapamil—Rash—Prednisolone—chronic obstructive pulmonary disease	7.78e-05	0.000639	CcSEcCtD
Verapamil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	7.77e-05	0.000639	CcSEcCtD
Verapamil—Fatigue—Prednisone—chronic obstructive pulmonary disease	7.73e-05	0.000635	CcSEcCtD
Verapamil—Headache—Prednisolone—chronic obstructive pulmonary disease	7.73e-05	0.000635	CcSEcCtD
Verapamil—Constipation—Prednisone—chronic obstructive pulmonary disease	7.67e-05	0.00063	CcSEcCtD
Verapamil—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	7.39e-05	0.000607	CcSEcCtD
Verapamil—Nausea—Prednisolone—chronic obstructive pulmonary disease	7.33e-05	0.000602	CcSEcCtD
Verapamil—Urticaria—Prednisone—chronic obstructive pulmonary disease	7.12e-05	0.000585	CcSEcCtD
Verapamil—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	6.61e-05	0.000543	CcSEcCtD
Verapamil—Asthenia—Prednisone—chronic obstructive pulmonary disease	6.43e-05	0.000529	CcSEcCtD
Verapamil—Pruritus—Prednisone—chronic obstructive pulmonary disease	6.34e-05	0.000521	CcSEcCtD
Verapamil—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.13e-05	0.000504	CcSEcCtD
Verapamil—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.93e-05	0.000487	CcSEcCtD
Verapamil—Vomiting—Prednisone—chronic obstructive pulmonary disease	5.7e-05	0.000469	CcSEcCtD
Verapamil—Rash—Prednisone—chronic obstructive pulmonary disease	5.65e-05	0.000465	CcSEcCtD
Verapamil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	5.65e-05	0.000464	CcSEcCtD
Verapamil—Headache—Prednisone—chronic obstructive pulmonary disease	5.62e-05	0.000462	CcSEcCtD
Verapamil—Nausea—Prednisone—chronic obstructive pulmonary disease	5.33e-05	0.000438	CcSEcCtD
Verapamil—SCN5A—Axon guidance—IL6—chronic obstructive pulmonary disease	1.27e-05	0.000157	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.27e-05	0.000156	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.27e-05	0.000156	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.27e-05	0.000156	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.27e-05	0.000156	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.27e-05	0.000156	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.26e-05	0.000155	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—IL6—chronic obstructive pulmonary disease	1.26e-05	0.000155	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.26e-05	0.000155	CbGpPWpGaD
Verapamil—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.25e-05	0.000154	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.25e-05	0.000154	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.22e-05	0.00015	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.21e-05	0.000149	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.21e-05	0.000149	CbGpPWpGaD
Verapamil—ABCC1—Disease—KL—chronic obstructive pulmonary disease	1.2e-05	0.000148	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.19e-05	0.000147	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.19e-05	0.000147	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.19e-05	0.000146	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.18e-05	0.000146	CbGpPWpGaD
Verapamil—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.18e-05	0.000146	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.18e-05	0.000146	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.18e-05	0.000145	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.17e-05	0.000144	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.17e-05	0.000144	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.17e-05	0.000144	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.17e-05	0.000144	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.16e-05	0.000143	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.16e-05	0.000143	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.16e-05	0.000142	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.15e-05	0.000142	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.15e-05	0.000142	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.15e-05	0.000141	CbGpPWpGaD
Verapamil—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.14e-05	0.00014	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.14e-05	0.00014	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.13e-05	0.000139	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.13e-05	0.000139	CbGpPWpGaD
Verapamil—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.13e-05	0.000139	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.12e-05	0.000138	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.12e-05	0.000138	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.12e-05	0.000138	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.12e-05	0.000138	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.12e-05	0.000138	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.11e-05	0.000137	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.11e-05	0.000136	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.1e-05	0.000136	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.1e-05	0.000136	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.09e-05	0.000134	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.08e-05	0.000133	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.08e-05	0.000133	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.07e-05	0.000132	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.07e-05	0.000132	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.07e-05	0.000132	CbGpPWpGaD
Verapamil—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.07e-05	0.000132	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.07e-05	0.000132	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.07e-05	0.000131	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.07e-05	0.000131	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.06e-05	0.000131	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.05e-05	0.00013	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.04e-05	0.000129	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.04e-05	0.000129	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.04e-05	0.000128	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.04e-05	0.000128	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.03e-05	0.000127	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.03e-05	0.000127	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.02e-05	0.000126	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.02e-05	0.000125	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.02e-05	0.000125	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.01e-05	0.000125	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.01e-05	0.000124	CbGpPWpGaD
Verapamil—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.9e-06	0.000122	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.89e-06	0.000122	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.89e-06	0.000122	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	9.88e-06	0.000122	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—TGFB1—chronic obstructive pulmonary disease	9.87e-06	0.000121	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.8e-06	0.000121	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.75e-06	0.00012	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.71e-06	0.00012	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.51e-06	0.000117	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.4e-06	0.000116	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.39e-06	0.000116	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.31e-06	0.000115	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	9.29e-06	0.000114	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.18e-06	0.000113	CbGpPWpGaD
Verapamil—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.13e-06	0.000112	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—IL6—chronic obstructive pulmonary disease	9.09e-06	0.000112	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.09e-06	0.000112	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—ALB—chronic obstructive pulmonary disease	9.02e-06	0.000111	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—IL6—chronic obstructive pulmonary disease	9e-06	0.000111	CbGpPWpGaD
Verapamil—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	8.98e-06	0.000111	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	8.93e-06	0.00011	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.92e-06	0.00011	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.9e-06	0.00011	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.78e-06	0.000108	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.66e-06	0.000107	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—NOS3—chronic obstructive pulmonary disease	8.63e-06	0.000106	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.62e-06	0.000106	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—ALB—chronic obstructive pulmonary disease	8.61e-06	0.000106	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—ALB—chronic obstructive pulmonary disease	8.54e-06	0.000105	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	8.53e-06	0.000105	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.49e-06	0.000104	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.46e-06	0.000104	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	8.36e-06	0.000103	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.34e-06	0.000103	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.3e-06	0.000102	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.28e-06	0.000102	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—NOS3—chronic obstructive pulmonary disease	8.23e-06	0.000101	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	8.19e-06	0.000101	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.18e-06	0.000101	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—NOS3—chronic obstructive pulmonary disease	8.17e-06	0.000101	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—TP53—chronic obstructive pulmonary disease	8.12e-06	0.0001	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.09e-06	9.97e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	8e-06	9.85e-05	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	7.96e-06	9.8e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.83e-06	9.64e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.77e-06	9.57e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.76e-06	9.56e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.75e-06	9.55e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.74e-06	9.53e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.72e-06	9.51e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.66e-06	9.43e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—ALB—chronic obstructive pulmonary disease	7.51e-06	9.24e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	7.49e-06	9.22e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	7.47e-06	9.2e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.37e-06	9.07e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	7.3e-06	8.99e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.22e-06	8.89e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.2e-06	8.86e-05	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—NOS3—chronic obstructive pulmonary disease	7.18e-06	8.84e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.13e-06	8.78e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.12e-06	8.77e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.08e-06	8.72e-05	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	7.02e-06	8.64e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—ALB—chronic obstructive pulmonary disease	7.02e-06	8.64e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.01e-06	8.63e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	6.93e-06	8.53e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—ALB—chronic obstructive pulmonary disease	6.91e-06	8.51e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	6.89e-06	8.48e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.88e-06	8.47e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.82e-06	8.4e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.76e-06	8.33e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.73e-06	8.28e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—ALB—chronic obstructive pulmonary disease	6.73e-06	8.28e-05	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—NOS3—chronic obstructive pulmonary disease	6.71e-06	8.26e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.64e-06	8.17e-05	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—NOS3—chronic obstructive pulmonary disease	6.61e-06	8.14e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.61e-06	8.14e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.46e-06	7.96e-05	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—NOS3—chronic obstructive pulmonary disease	6.43e-06	7.92e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.4e-06	7.89e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	6.32e-06	7.79e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	6.3e-06	7.76e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.29e-06	7.75e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.26e-06	7.71e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	6.19e-06	7.62e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.11e-06	7.52e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	6.04e-06	7.43e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	6.02e-06	7.41e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	5.86e-06	7.21e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.83e-06	7.17e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.77e-06	7.1e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.76e-06	7.09e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.74e-06	7.07e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.71e-06	7.03e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	5.69e-06	7.01e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.66e-06	6.97e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	5.65e-06	6.95e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	5.64e-06	6.95e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.61e-06	6.91e-05	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.6e-06	6.9e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.53e-06	6.81e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	5.51e-06	6.78e-05	CbGpPWpGaD
Verapamil—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.35e-06	6.59e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.28e-06	6.5e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	5.27e-06	6.49e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.26e-06	6.48e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.2e-06	6.4e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	5.19e-06	6.39e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.16e-06	6.35e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	5.15e-06	6.34e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.08e-06	6.25e-05	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.04e-06	6.21e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	5.01e-06	6.17e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5e-06	6.16e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.89e-06	6.02e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.88e-06	6e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.86e-06	5.98e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.82e-06	5.94e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.79e-06	5.9e-05	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.79e-06	5.9e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.78e-06	5.89e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.74e-06	5.84e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	4.64e-06	5.71e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	4.6e-06	5.66e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.49e-06	5.53e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.47e-06	5.5e-05	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.44e-06	5.46e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.4e-06	5.42e-05	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	4.4e-06	5.41e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.34e-06	5.34e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.28e-06	5.27e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	4.28e-06	5.27e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.23e-06	5.21e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.23e-06	5.21e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.18e-06	5.14e-05	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.09e-06	5.04e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.99e-06	4.91e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.99e-06	4.91e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	3.98e-06	4.9e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.96e-06	4.87e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.93e-06	4.85e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	3.9e-06	4.81e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.9e-06	4.8e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.89e-06	4.79e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.78e-06	4.65e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.76e-06	4.63e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.72e-06	4.58e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.69e-06	4.54e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.67e-06	4.51e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.63e-06	4.48e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.48e-06	4.28e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.45e-06	4.24e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	3.4e-06	4.19e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.39e-06	4.18e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.38e-06	4.16e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.33e-06	4.1e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	3.32e-06	4.09e-05	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.25e-06	4e-05	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	3.18e-06	3.91e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.13e-06	3.85e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.11e-06	3.82e-05	CbGpPWpGaD
Verapamil—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	3e-06	3.69e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.94e-06	3.63e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	2.88e-06	3.54e-05	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	2.75e-06	3.39e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.61e-06	3.21e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.57e-06	3.17e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	2.57e-06	3.16e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	2.51e-06	3.09e-05	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	2.46e-06	3.03e-05	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.4e-06	2.95e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.4e-06	2.95e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.36e-06	2.91e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	2.34e-06	2.88e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.27e-06	2.8e-05	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.26e-06	2.78e-05	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.24e-06	2.76e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2e-06	2.46e-05	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.91e-06	2.36e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.54e-06	1.9e-05	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.48e-06	1.82e-05	CbGpPWpGaD
